Cargando…
Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results
AIM: To evaluate the role of a therapeutic regimen with plasma exchange, intravenous immunoglobulins and rituximab in chronic-active antibody-mediated rejection (cAMR) settings. METHODS: We compared 21 kidney transplant recipients (KTRs) with a diagnosis of cAMR in a retrospective case-control analy...
Autores principales: | Mella, Alberto, Gallo, Ester, Messina, Maria, Caorsi, Cristiana, Amoroso, Antonio, Gontero, Paolo, Verri, Aldo, Maletta, Francesca, Barreca, Antonella, Fop, Fabrizio, Biancone, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134268/ https://www.ncbi.nlm.nih.gov/pubmed/30211026 http://dx.doi.org/10.5500/wjt.v8.i5.178 |
Ejemplares similares
-
Clinical outcomes and temporal trends of immunological and non-immunological rare diseases in adult kidney transplant
por: Gallo, Ester, et al.
Publicado: (2021) -
Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction
por: Gallo, Ester, et al.
Publicado: (2020) -
Profound hyperacute cardiac allograft rejection rescue with biventricular mechanical circulatory support and plasmapheresis, intravenous immunoglobulin, and rituximab therapy
por: Kaczorowski, David J, et al.
Publicado: (2013) -
Vitamin D deficiency may predispose patients to increased risk of kidney transplant rejection
por: Buyukdemirci, Semih, et al.
Publicado: (2022) -
Ineffective esophageal motility is associated with acute rejection after lung transplantation independent of gastroesophageal reflux
por: Lo, Wai-Kit, et al.
Publicado: (2023)